To begin the process of evaluating and licensing APL technology, contact us to begin a dialogue. OTT will secure a nondisclosure agreement and begin with a preliminary meeting including the interested party and investor(s) to determine an appropriate licensing strategy. APL’s OTT staff are technical, business, and administrative professionals with many years of technology transfer and industry experience.
The APL Office of Technology Transfer is responsible for all aspects of marketing and licensing APL technology. OTT engages in an aggressive program to commercialize its technology through successful partnerships with business and industry. OTT uses a variety of tools to accomplish the technology transfer goals of APL, including license and option agreements, cooperative research agreements, strategic partnering, and spin-off companies.
All technology transfer license agreements are negotiated and executed through the Office of Technology Transfer. OTT will work to negotiate agreements that share risk and reward and give the technology the best chance of success in the marketplace.
APL seeks licensees who have the necessary resources and planning to successfully commercialize the licensed technology. OTT will qualify the company or companies to ensure that they have the sufficient capital, infrastructure, and business focus to get a product on the market.
APL is committed to having a positive impact on the economic health of the State of Maryland and as such will seek to work with local companies when possible.
Yes. However, technologies developed with federal funding require a substantial part of the product manufacturing to be done in the United States. Federal export-control statutes and regulations also may affect licensing outside the United States. These are assessed on a case-by-case basis.
Typically, APL looks for licensing terms that include a license execution fee; royalties on sales of products; milestone, annual, and diligence payments; and patent reimbursement.
A sample APL license agreement can be viewed here.
Yes. From a starting point of basic business practice, OTT will tailor our standard agreements to fit each situation. Our goal is to accurately value the technology and structure terms that are fair and reasonable for the given opportunity.
Turnaround time varies from case to case, but OTT works from preapproved agreement language and has signature authority for technology transfer agreements, which helps to expedite the process.
Yes. APL will seek a license arrangement that will give the technology the best chance of success in the marketplace. While in certain situations we prefer to execute nonexclusive license agreements, exclusive, nonexclusive, co-exclusive, and field-of-use agreements are common.
If research funding is associated with an option or license agreement, it will be included as a separate term in the license agreement, and a separate research and development contract will be executed. OTT works closely with the APL Contracts Group in these instances.
Annually, one to two new companies form around APL technology. The Lab may take a minority equity share as a partial payment for the license to the technology; however, outside sources are needed for seed and venture funding.